These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2014-005523-27||Multicenter prospective randomized trial of the effect of rivaroxaban on survival and development of complications of portal hypertension in patients with cirrhosis||not-yet-due|
|Completed, but no date||2015-004238-85||Ictal brain SPECT in the premotor stage of Parkinson disease||bad-data|
|Ongoing||2016-000347-14||Cell proliferation in pulmonary hypertension: mollecular imaging detection by FDG PET. Comparative study between patients and healthy subjects||not-yet-due|
|Exempt||2016-002972-29||Pilot study on the infusion of differentiated autologous T-cells from peripheral blood, expanded and transduced with a lentivirus to express a chimeric antigen receptor with anti-CD19 specificity (A3B...||not-yet-due|
|Not reported Terminated||2016-003451-30||Subjects with subjective cognitive decline: 18F-Florbetaben Positrón Emission Tomography Study.||2019-02-28||due-trials|
|Listed as ongoing, but also has a completion date and reported results||2016-004499-23||Safety and tolerability of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosis: a multicenter, double-blind, placebo controlled randomized clinical trial.||2018-03-12||bad-data|
|Ongoing||2018-001698-25||Efficacy of the combination of simvastatin plus rifaximin in patients with decompensated cirrhosis to prevent ACLF development: a multicenter, double-blind, placebo controlled randomized clinical tria...||not-yet-due|